Showing results (301-310 of 366) with videos related to
Sort By:
Pageof 37
Molecular Cell|December 31, 2002
Activation of the ATPase activity of hsp90 by the stress-regulated cochaperone aha1Barry Panaretou, Giuliano Siligardi, Philippe Meyer, et al.Molecular Cancer Therapeutics|June 11, 2009
Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumorsRichard D Baird, Jos Kitzen, Paul A Clarke, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2011
A phase I study of the heat shock protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced solid tumorsSimon Pacey, Richard H Wilson, Mike Walton, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
In vitro and in vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine and CYC202Florence I Raynaud, Steven R Whittaker, Peter M Fischer, et al.Cancer Research|July 24, 2015
Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug ResistanceMark D Gurden, Isaac M Westwood, Amir Faisal, et al.Plos One|January 19, 2012
Mechanism-based screen for G1/S checkpoint activators identifies a selective activator of EIF2AK3/PERK signallingSimon R Stockwell, Georgina Platt, S Elaine Barrie, et al.Cancer Research|July 9, 2010
A useful approach to identify novel small-molecule inhibitors of Wnt-dependent transcriptionKenneth Ewan, Bozena Pajak, Mark Stubbs, et al.Nature Communications|February 14, 2025
Structural insights into human brachyury DNA recognition and discovery of progressible binders for cancer therapyJoseph A Newman, Angeline E Gavard, Nergis Imprachim, et al.Cancer Discovery|March 30, 2013
Histone H3.3. mutations drive pediatric glioblastoma through upregulation of MYCNLynn Bjerke, Alan Mackay, Meera Nandhabalan, et al.Plos One|April 15, 2009
Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug developmentDorine A Bax, Suzanne E Little, Nathalie Gaspar, et al.Pageof 37